BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33509807)

  • 1. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
    Kim SH; Singh KB; Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
    Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
    J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
    Kim SH; Hahm ER; Singh KB; Singh SV
    Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER; Lee J; Abella T; Singh SV
    Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
    Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
    J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells.
    Kim SH; Hahm ER; Singh SV
    Mol Carcinog; 2023 Oct; 62(10):1449-1459. PubMed ID: 37265428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
    Kim SH; Singh SV
    Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
    Stan SD; Hahm ER; Warin R; Singh SV
    Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
    Hahm ER; Lee J; Huang Y; Singh SV
    Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
    Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
    Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
    Hahm ER; Kim SH; Singh KB; Singh SV
    Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
    Lee J; Hahm ER; Singh SV
    Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Krüppel-like Factor 4-p21
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
    Lee J; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
    Hahm ER; Singh SV
    Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
    Kim SH; Singh SV
    Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
    Singh KB; Hahm ER; Kim SH; Singh SV
    Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.